Protocol No. 156-08-271: Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease (ADPKD)